@article{a7f1a1fd8a61429980e722fec6bf734b,
title = "Assessment and Management of Acute Coronary Syndromes (ACS): A Canadian Perspective on Current Guideline-Recommended Treatment - Part 1: Non-ST-Segment Elevation ACS",
author = "Fitchett, {David H.} and Pierre Theroux and Brophy, {James M.} and Cantor, {Warren J.} and Cox, {Jafna L.} and Milan Gupta and Heather Kertland and Mehta, {Shamir R.} and Welsh, {Robert C.} and Goodman, {Shaun G.}",
note = "Funding Information: Pierre Theroux has served as a consultant for AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, and sanofi-aventis. Dr Theroux has also received speaker honoraria from AstraZeneca, Boeringher Ingelheim, Bristol-Myers Squibb, and sanofi-aventis, and he has received a research grant from Merck . Funding Information: Publication of this article was supported by AstraZeneca Canada Inc. and Bristol-Myers Squibb Canada and sanofi-aventis Canada. ",
year = "2011",
month = nov,
doi = "10.1016/j.cjca.2011.08.110",
language = "English",
volume = "27",
pages = "S387--S401",
journal = "Canadian Journal of Cardiology",
issn = "0828-282X",
publisher = "Pulsus Group Inc.",
number = "6 SUPPL.",
}